US Patent 11958893 Methods for modulating an immune response
Patent 11958893 was granted and assigned to Cue Biopharma on April, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11958893 Methods for modulating an immune response
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.